Literature DB >> 10716498

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

P Clayette, S Jorajuria, D Dormont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10716498     DOI： 10.1097/00002030-200002180-00004

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

Review 1.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.

Authors:  Cécile Goujard; Mayeule Legrand; Xavière Panhard; Bertrand Diquet; Xavier Duval; Gilles Peytavin; Isabelle Vincent; Christine Katlama; Catherine Leport; Bénédicte Bonnet; Dominique Salmon-Céron; France Mentré; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  St Johns wort increases expression of P-glycoprotein: implications for drug interactions.

Authors:  Martina Hennessy; D Kelleher; J P Spiers; M Barry; P Kavanagh; D Back; F Mulcahy; J Feely
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.